Carbon nanotubes as an emerging nanocarrier for the delivery of doxorubicin for improved chemotherapy
Source abstract
Abstract
Carbon nanotubes (CNTs), a versatile nanocarrier for doxorubicin (DOX) delivery had attracted significant attention in drug delivery of pharmaceuticals. Several properties such as high surface area, high drug loading capacity, stability, ease of functionalization, ultrahigh length to diameter ratio and good cellular uptake make them preferred nanocarrier as multipurpose drug delivery system. Several surface properties of CNTs can be easily modified by covalent/noncovalent functionalization, which can make CNTs a profound nanomaterial. Hydrophobic surface of CNTs facilitated π-π stacking interactions, with several drugs and therapeutic agents having aromatic ring in their structure, for example anthracyclines. In case some drug molecules, electrostatic interaction between drug and CNTs comes into the picture. DOX, an anthracycline anticancer drug, can easily adsorb on the surface of CNTs by π-π stacking interactions. In present article, we have reviewed various CNTs based drug delivery systems for the delivery of DOX alone or in combination with genetic materials and other drug molecules. In addition, we described recent updates in CNTs based drug delivery system for the delivery of DOX, we covered adsorption and desorption, different types of functionalization, to alter the properties of CNTs in vitro and in vivo. CNT attached many targeting ligands for the targeted delivery of DOX have also been discussed.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Carbon Nanotubes in Composites · Graphene and Nanomaterials Applications · Graphene research and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Advanced hybrid nanomaterials for biomedical applications10.1016/j.pmatsci.2020.100686 ↗
2. Carbon nanotubes: an effective platform for biomedical electronics10.1016/j.bios.2019.111919 ↗
3. Therapeutic and diagnostic potential of nanomaterials for enhanced biomedical applications10.1016/j.colsurfb.2019.05.008 ↗
4. Dendrimer as nanocarrier for drug delivery10.1016/j.progpolymsci.2013.07.005 ↗
5. Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery10.1016/j.drudis.2014.12.012 ↗
6. Carbon nanotube - a review on synthesis, properties and plethora of applications in the field of biomedical science
7. A review of nanocarriers for the delivery of small interfering RNA10.1016/j.biomaterials.2012.06.068 ↗
8. Carbon nanotubes in cancer diagnosis and therapy10.1016/j.bbcan.2010.02.004 ↗
9. Pentagons, heptagons and negative curvature in graphite microtubule growth10.1038/356776a0 ↗
10. Carbon nanotubes: a novel material for multifaceted applications in human healthcare10.1039/C6CS00517A ↗
11. Carbon nanotubes, science and technology part (I) structure, synthesis and characterisation10.1016/j.arabjc.2010.08.022 ↗
12. Applications of carbon nanotubes-based biomaterials in biomedical nanotechnology10.1166/jnn.2006.197 ↗
13. Carbon nanotubes: properties and application10.1016/j.mser.2003.10.001 ↗
14. Carbon dots: emerging theranostic nanoarchitectures10.1016/j.drudis.2018.01.006 ↗
15. Carbon nanotube scaffolds as emerging nanoplatform for myocardial tissue regeneration: a review of recent developments and therapeutic implications10.1016/j.biopha.2018.05.066 ↗
16. Introduction to carbon materials research
17. Science of fullerenes and carbon nanotubes by M. S. Dresselhaus (MIT), G. Dresselhaus (MIT), and P. C. Eklund (University of Kentucky). Academic Press: San Diego. 1996, xviii + 965 pp. ISBN 0-12-221820-510.1021/ja965593l ↗
18. Carbon nanotube exploration in cancer cell lines10.1016/j.drudis.2012.05.003 ↗
19. Validating the anticancer potential of carbon nanotube-based therapeutics through cell line testing10.1016/j.drudis.2015.05.004 ↗
20. Biomedical applications and toxicological aspects of functionalized carbon nanotubes10.1615/CritRevTherDrugCarrierSyst.2018014419 ↗
21. Young’s modulus of single-walled nanotubes10.1103/PhysRevB.58.14013 ↗
22. Carbon Nanotubes (CNTs): a novel drug delivery tool in brain tumor treatment, nanotechnology-based target
23. Strength and breaking mechanism of multiwalled carbon nanotubes under tensile load10.1126/science.287.5453.637 ↗
24. Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues10.1016/j.nano.2008.04.003 ↗
25. Load transfer and deformation mechanisms in carbon nanotube-polystyrene composites10.1063/1.126500 ↗
26. Conductivity scaling with bundle length and diameter in single walled carbon nanotube networks10.1063/1.2356999 ↗
27. Aligned single-wall carbon nanotubes in composites by melt processing methods10.1016/S0009-2614(00)01013-7 ↗
28. Selective probing and imaging of cells with single walled carbon nanotubes as near-infrared fluorescent molecules10.1021/nl072949q ↗
29. In vivo fate of carbon nanotubes with different physicochemical properties for gene delivery applications10.1021/acsami.7b00677 ↗
30. Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair10.1021/nn5020787 ↗
31. Carbon nanotubes in biomedical applications: factors, mechanisms, and remedies of toxicity10.1021/acs.jmedchem.5b01770 ↗
32. Functionalized carbon nanotubes in drug design and discovery10.1021/ar700089b ↗
33. Carbon nanotubes for biological and biomedical applications10.1088/0957-4484/18/41/412001 ↗
34. CNT-based and MSN-based organic/inorganic hybrid nanocomposites for biomedical applications10.1021/bk-2017-1253.ch009 ↗
35. Applications of functionalized carbon nanotubes for the therapy and diagnosis of cancer10.3390/polym9010013 ↗
36. Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin10.1016/j.colsurfb.2015.06.027 ↗
37. In vivo antitumor activity of folate-conjugated cholic acid-polyethylenimine micelles for the codelivery of doxorubicin and siRNA to colorectal adenocarcinomas10.1021/acs.molpharmaceut.5b00827 ↗
38. pH-responsive triblock copolymeric micelles decorated with a cell-penetrating peptide provide efficient doxorubicin delivery10.1186/s11671-016-1755-4 ↗
39. Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics
40. Clinical pharmacokinetics of doxorubicin10.2165/00003088-198815010-00002 ↗
41. Doxorubicin and siRNA codelivery via chitosan-coated pH-responsive mixed micellar polyplexes for enhanced cancer therapy in multidrug-resistant tumors10.1021/acs.molpharmaceut.6b00776 ↗
42. Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies10.2165/00003088-200342050-00002 ↗
43. Dendrimer-entrapped gold nanoparticles as promising nanocarriers for anticancer therapeutics and imaging10.1016/j.pmatsci.2019.03.003 ↗
44. Doxorubicin and siRNA Codelivery via chitosan-coated pH-responsive mixed micellar polyplexes for enhanced cancer therapy in multidrug-resistant tumors10.1021/acs.molpharmaceut.6b00776 ↗
45. Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro / in vivo live cell imaging10.1016/j.jconrel.2013.08.034 ↗
46. Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors10.1158/1078-0432.CCR-05-0343 ↗
47. Bilosomes in the context of oral immunization: development, challenges and opportunities10.1016/j.drudis.2016.03.013 ↗
48. Rate of biodistribution of STEALTH® liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity10.1016/S0005-2736(02)00661-2 ↗
49. Doxorubicin-loaded composite nanogels for cancer treatment10.1016/j.jconrel.2020.08.033 ↗
50. Single walled carbon nanotubes as drug delivery vehicles: targeting doxorubicin to tumors10.1016/j.biomaterials.2011.11.004 ↗
51. Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes10.1016/j.biomaterials.2009.07.025 ↗
52. Triple functionalisation of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapy10.1016/j.carbon.2009.03.057 ↗
53. Green and direct functionalization of poly (ethylene glycol) grafted polymers onto single walled carbon nanotubes: effective nanocarrier for doxorubicin delivery10.1016/j.jiec.2019.11.025 ↗
54. A comparative study on non-covalent functionalization of carbon nanotubes by chitosan and its derivatives for delivery of doxorubicin10.1016/j.cplett.2015.10.075 ↗
55. Ideas of Quantum Chemistry - 2nd ed. (n.d.).
56. Theorical investigation of adsorption mechanism of doxorubicin anticancer drug on the pristine and functionalized single-walled carbon nanotube surface as a drug delivery vehicle: a DFT study10.1016/j.molliq.2020.114890 ↗
57. pH-controlled doxorubicin anticancer loading and release from carbon nanotube noncovalently modified by chitosan: MD simulations10.1016/j.jmgm.2016.09.011 ↗
58. Adsorption and encapsulation of the drug doxorubicin on covalent functionalized carbon nanotubes: a scrutinized study by using molecular dynamics simulation and quantum mechanics calculation10.1016/j.jmgm.2018.12.009 ↗
59. Development and evaluation of pH-responsive single-walled carbon nanotube-doxorubicin complexes in cancer cells
60. Effect of intratumoral injection on the biodistribution and therapeutic potential of novel chemophor EL-modified single-walled nanotube loading doxorubicin10.3109/03639045.2011.637050 ↗
61. Catalytic growth of carbon filaments10.1016/0008-6223(89)90062-6 ↗
62. Catalytic growth of carbon microtubules with fullerene structure10.1063/1.108857 ↗
63. The study of carbon nanotubules produced by catalytic method10.1016/0009-2614(94)00467-6 ↗
64. Carbon nanotube synthesis in a flame using laser ablation for in situ catalyst generation10.1007/s00339-003-2196-3 ↗
65. Cobalt-catalysed growth of carbon nanotubes with single-atomic-layer walls10.1038/363605a0 ↗
66. Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics
67. Multi-walled carbon nanotubes exacerbate doxorubicin-induced cardiotoxicity by altering gut microbiota and pulmonary and colonic macrophage phenotype in mice10.1016/j.tox.2020.152410 ↗
68. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes10.1002/adhm.201200389 ↗
69. Tunable doxorubicin release from polymer-gated multiwalled carbon nanotubes10.1016/j.ijpharm.2016.10.010 ↗
70. Development of medical-grade, discrete, multi-walled carbon nanotubes as drug delivery molecules to enhance the treatment of hematological malignancies10.1016/j.nano.2019.102025 ↗
71. PEGylated multi-walled carbon nanotubes as versatile vector for tumor-specific intracellular triggered release with enhanced anti-cancer efficiency: optimization of length and PEGylation degree10.1016/j.colsurfb.2018.02.041 ↗
72. Adsorption and desorption of doxorubicin on oxidized carbon nanotubes10.1016/j.colsurfb.2012.04.013 ↗
73. Development of magnetic multiwalled carbon nanotubes combined with near-infrared radiation-assisted desorption for the determination of tissue distribution of doxorubicin liposome injects in rats10.1016/j.chroma.2011.05.060 ↗
74. Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes10.1016/j.colsurfb.2011.08.001 ↗
75. Chondroitin sulphate and α-tocopheryl succinate tethered multiwalled carbon nanotubes for dual-action therapy of triple-negative breast cancer
76. Doxorubicin loaded folate-targeted carbon nanotubes: preparation, cellular internalization, in vitro cytotoxicity and disposition kinetic study in the isolated perfused rat liver10.1016/j.msec.2014.01.055 ↗
77. Ex vivo and in vivo performance of anti-cancer drug loaded carbon nanotubes10.1016/j.jddst.2017.07.011 ↗
78. Galactosylated chitosan-grafted multiwall carbon nanotubes for pH-dependent sustained release and hepatic tumor-targeted delivery of doxorubicin in vivo10.1016/j.colsurfb.2015.06.003 ↗
79. Hyaluronic acid-modified multiwalled carbon nanotubes for targeted delivery of doxorubicin into cancer cells10.1016/j.carres.2014.06.030 ↗
80. Recent advances in carbon nanomaterials for biomedical applications: a review
81. Chemotherapy for advanced gastric cancer
82. Low-density lipoprotein-coupled micelles with reduction and ph dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor10.2147/IJN.S126310 ↗
83. Aptamer-mediated targeted delivery of therapeutics: an update10.3390/ph9040069 ↗
84. The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer10.3390/pharmaceutics5020353 ↗
85. siRNA delivery into human T cells and primary cells with carbon-nanotube transporters10.1002/anie.200604295 ↗
86. Enhanced lysosomal escape of pH-responsive polyethylenimine-betaine functionalized carbon nanotube for the Codelivery of survivin small interfering RNA and doxorubicin10.1021/acsami.8b20810 ↗
87. Simultaneous fluorescence imaging monitoring of the programmed release of dual drugs from a hydrogel-carbon nanotube delivery system10.1016/j.snb.2018.06.064 ↗
88. pH-sensitive co-adsorption/release of doxorubicin and paclitaxel by carbon nanotube, fullerene, and graphene oxide in combination with N-isopropylacrylamide: a molecular dynamics study10.3390/biom8040127 ↗
89. An innovative MWCNTs/DOX/TC nanosystem for chemo-photothermal combination therapy of cancer10.1016/j.nano.2017.07.002 ↗
90. Magnetofluorescent Fe3O4/carbon quantum dots coated single-walled carbon nanotubes as dual-modal targeted imaging and chemo/photodynamic/photothermal triple-modal therapeutic agents10.1016/j.cej.2018.01.081 ↗
91. Purification of CVD synthesized single-wall carbon nanotubes by different acid oxidation treatments10.1088/0957-4484/15/11/047 ↗
92. Interactions of single-wall carbon nanotubes with endothelial cells10.1016/j.nano.2009.08.001 ↗
93. An overview of nanotoxicity and nanomedicine research: principles, progress and implications for cancer therapy10.1039/C5TB00956A ↗
94. Synthesis and applications of amino-functionalized carbon nanomaterials10.1039/D0CC05316C ↗
95. Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice10.1016/j.toxlet.2008.07.020 ↗
96. Synthesis of amino-functionalized carbon nanotubes and their applications10.2174/1385272822666180731143454 ↗
97. Silanization of multi-walled carbon nanotubes and the study of its effects on the properties of polyurethane rigid foam nanocomposites10.1016/j.compositesa.2018.03.028 ↗
98. Understanding the mechanical and conductive properties of carbon nanotube fibers for smart electronics
99. The cancer targeting potential of d-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes10.1016/j.biomaterials.2014.02.022 ↗
100. Poly(ethylene glycol)-conjugated multi-walled carbon nanotubes as an efficient drug carrier for overcoming multidrug resistance10.1016/j.taap.2010.10.012 ↗